Switch to:
Progenics Pharmaceuticals Inc (NAS:PGNX)
Cash And Cash Equivalents
$85.23 Mil (As of Sep. 2014)

Progenics Pharmaceuticals Inc's quarterly cash and cash equivalents declined from Mar. 2014 ($94.04 Mil) to Jun. 2014 ($85.35 Mil) and declined from Jun. 2014 ($85.35 Mil) to Sep. 2014 ($85.23 Mil).

Progenics Pharmaceuticals Inc's annual cash and cash equivalents declined from Dec. 2011 ($70.11 Mil) to Dec. 2012 ($58.84 Mil) but then increased from Dec. 2012 ($58.84 Mil) to Dec. 2013 ($65.86 Mil).


Cash and cash equivalents on banks book.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Progenics Pharmaceuticals Inc Annual Data

BS_CashAndCashEquivalents 5.2367.0711.9510.4256.1990.9047.9270.1158.8465.86

Progenics Pharmaceuticals Inc Quarterly Data

BS_CashAndCashEquivalents 47.8241.1058.8455.2879.2275.6065.8694.0485.3585.23
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial